Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Planning and Dissemination Grant - Institute Community Support

Institut de recherches cliniques de Montréal

$10,000.00

DNA deamination in adaptive and innate immunity: 20 years after the discovery of Activation induced deaminase

EF 2019-20

Résumé
This meeting attracts scientists studying of a unique type of enzymes that edit the genome of cells and viruses. In 2020 we mark the 20th anniversary of the landmark discovery that the enzyme Activation induced deaminase (AID) underpins antibody-mediated immunity. AID remodels the antibody genes to improve the quality of the antibodies to fight pathogens. This finding illuminated the nature of a class of antibodies that can neutralize a wide range of viruses, paving the way for the rational design of vaccines. We then learned that AID-related enzymes named APOBECs use a similar mutagenic activity to defend cells from viruses. Moreover, collateral damage from the mutagenic activity of AID/APOBECs can cause cancer. Thus, AID hatched several health and immunity research fields, which often advance in parallel. This anniversary prompted us to organize a forum to bring those fields together and exchange the latest advances and identify areas of potential collaboration, seeking to "strengthen and coordinate infection and immunity research", a strategic research priority of the Institute of Infection and Immunity. This will be the 5th of a series of meetings started in 2008, organized by AID/APOBEC scientists and attracting most of the ~50 laboratories working on these enzymes. Donations from the participating institutions, vendors and government agencies, cover the conference and hospitality costs to enable the participation of research groups regardless of their funding situation. The meeting has a workshop format of oral presentations to encourage discussion. Held in Quebec, this meeting will showcase Canadian research to immunologists of the highest caliber, including the 2018 Nobel Laureate in in Medicine or Physiology, and provide a cost-free learning experience for local trainees, thus "supporting research and helping to build research capacity in the areas of infectious disease and the body's immune system", as mandated to the Institute of Infection and Immunity.
Programme
Planning and Dissemination Grant - Institute Community Support
Emplacement
Quebec, Canada
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
411857
Name
Di Noia Javier M
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Planning and Dissemination - III
Projecttitle
DNA deamination in adaptive and innate immunity: 20 years after the discovery of Activation induced deaminase
Programtype2
Miscellaneous Programs
Orgnameinp2
Institut de recherches cliniques de Montréal
Cihramount2
$10,000
Cihrequipment2
$0
Programname2
Planning and Dissemination Grant - Institute Community Support
Keyworddelim
Antibodies; Hematological Cancer; Immune Response; Immunological Memory; Mutation
Abstract
This meeting attracts scientists studying of a unique type of enzymes that edit the genome of cells and viruses. In 2020 we mark the 20th anniversary of the landmark discovery that the enzyme Activation induced deaminase (AID) underpins antibody-mediated immunity. AID remodels the antibody genes to improve the quality of the antibodies to fight pathogens. This finding illuminated the nature of a class of antibodies that can neutralize a wide range of viruses, paving the way for the rational design of vaccines. We then learned that AID-related enzymes named APOBECs use a similar mutagenic activity to defend cells from viruses. Moreover, collateral damage from the mutagenic activity of AID/APOBECs can cause cancer. Thus, AID hatched several health and immunity research fields, which often advance in parallel. This anniversary prompted us to organize a forum to bring those fields together and exchange the latest advances and identify areas of potential collaboration, seeking to "strengthen and coordinate infection and immunity research", a strategic research priority of the Institute of Infection and Immunity. This will be the 5th of a series of meetings started in 2008, organized by AID/APOBEC scientists and attracting most of the ~50 laboratories working on these enzymes. Donations from the participating institutions, vendors and government agencies, cover the conference and hospitality costs to enable the participation of research groups regardless of their funding situation. The meeting has a workshop format of oral presentations to encourage discussion. Held in Quebec, this meeting will showcase Canadian research to immunologists of the highest caliber, including the 2018 Nobel Laureate in in Medicine or Physiology, and provide a cost-free learning experience for local trainees, thus "supporting research and helping to build research capacity in the areas of infectious disease and the body's immune system", as mandated to the Institute of Infection and Immunity.
Competitiondate
201909
Approvedterm2
1 yr 0 mth
Pinamesdelim
Di Noia, Javier M
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Infection & Immunity~ $10,000~ $0~